Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia.

[1] It is a selective 5-HT6 receptor antagonist.

[2]

This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.